Journal
Coffee is one of the most widely consumed beverages in the world. For some, it is an essential morning ritual. For others, it is seen as a stimulant to be approached with caution.
The scientific reality is more nuanced.
Over the past fifteen years, a growing body of epidemiological and mechanistic research has significantly reshaped our understanding of coffee’s effects on health. Far from being limited to caffeine alone, coffee contains hundreds of bioactive compounds, some of which exert measurable physiological effects.
When consumed in moderation, coffee may therefore be part of a broader strategy for metabolic health and longevity.
Coffee is often reduced to its primary stimulant: caffeine.
In reality, its matrix is far more complex. It contains:
These molecules interact with multiple biological systems, including energy metabolism, inflammation, the gut microbiome, and the central nervous system.
In other words, coffee acts as a network of biological signals rather than a single stimulant compound [4].
Large cohort studies consistently show associations between moderate coffee consumption and a reduced risk of several chronic diseases.
An umbrella review published in The BMJ, covering over 200 meta-analyses and observational studies, found that consumption of around 3–4 cups per day is associated with a lower risk of all-cause mortality and multiple chronic conditions [1].
Several health domains have been particularly studied:
Numerous prospective studies show an inverse association between coffee consumption and diabetes risk. Pooled analyses across international cohorts indicate that regular coffee drinkers have a significantly lower risk of developing type 2 diabetes, likely linked to the effects of coffee polyphenols on insulin sensitivity and glucose metabolism [1].
Several epidemiological studies have observed an association between coffee consumption and a reduced risk of Parkinson’s disease, potentially related to caffeine’s action on adenosine receptors and the modulation of dopaminergic pathways [2].
A large body of research shows that regular coffee consumption is associated with a lower risk of liver diseases, including fatty liver disease, fibrosis, and cirrhosis, likely through the anti-inflammatory and antioxidant effects of coffee’s polyphenols [1].
Multiple studies suggest that regular coffee drinkers show better preservation of certain cognitive functions and a lower risk of some neurodegenerative diseases, linked to the neuroprotective effects of caffeine and phenolic compounds [3].
These findings do not imply that coffee is a treatment. However, they suggest that, within a balanced lifestyle, it can be part of a diet supportive of metabolic health.
Caffeine primarily acts by blocking adenosine receptors, a molecule involved in the sensation of fatigue.
This mechanism increases alertness, focus, and perceived energy.
At moderate doses, caffeine can:
These effects largely explain the widespread use of coffee in professional, intellectual, and athletic contexts [4].
The polyphenols in coffee may also interact with the gut microbiome.
Some studies suggest they promote the growth of beneficial gut bacteria and contribute to the production of protective metabolites.
In addition, coffee’s antioxidant compounds help limit oxidative stress and low-grade inflammation—two processes involved in biological aging and metabolic diseases [4].
Another physiological effect of coffee relates to its interaction with the brain’s neurovascular system, which helps explain its role in certain migraine management strategies.
During a migraine attack, changes in the tone of cerebral blood vessels are observed.
Caffeine acts as a mild vasoconstrictor. It can reduce the dilation of certain intracranial vessels involved in migraine pain, which may help reduce the intensity of an attack in some individuals [5].
Caffeine is often combined with analgesic medications because it can enhance their effectiveness.
Studies show it may improve the absorption and action of certain compounds, including:
This combination is used in several formulations designed to treat headaches and migraines [6].
Caffeine also works by blocking adenosine receptors in the brain.
Adenosine:
By antagonizing these receptors, caffeine may reduce the neurovascular cascade involved in migraine attacks [5].
The relationship between caffeine and migraine remains paradoxical.
Depending on individual sensitivity and consumption patterns, caffeine may either relieve or trigger migraines.
Two common scenarios are observed:
Neurologists generally consider that above approximately 200–300 mg of caffeine per day, the risk of caffeine-related headaches may increase in sensitive individuals [5].
For individuals prone to migraines:
The effect of coffee on migraines is therefore highly individual and dependent on consumption habits.
While moderate coffee consumption is generally well tolerated and associated with several beneficial physiological effects, excessive intake can become problematic for some individuals.
Caffeine stimulates the sympathetic nervous system and may lead to:
In people with poorly controlled hypertension, cardiac rhythm disorders, or high sensitivity to caffeine, excessive coffee consumption may worsen these symptoms.
In such cases, reducing caffeine intake and observing individual responses is generally recommended.
As often in nutrition, the issue is not the presence of coffee, but the quantity consumed.
Most studies converge on a range considered safe for the majority of healthy adults.
This generally corresponds to 2 to 4 cups of coffee per day, or approximately 200 to 400 mg of caffeine.
Beyond this range, benefits do not increase and adverse effects become more likely.
As is often the case in nutrition, the question is not whether a food is “good” or “bad.”
It depends on metabolic context, dose, and overall lifestyle.
Within a balanced diet, coffee can absolutely have its place. When consumed reasonably, it provides several beneficial bioactive compounds.
The goal is not to eliminate coffee, but to integrate it with discernment.
[1] Poole R. et al. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. The BMJ, 2017. https://www.bmj.com/content/359/bmj.j5024
[2] Sääksjärvi K. et al. Prospective study of coffee consumption and risk of Parkinson’s disease. European Journal of Clinical Nutrition, 2008. https://pubmed.ncbi.nlm.nih.gov/17522612/
[3] Pergolizzi J. et al. Neurocognitive and neurological effects of coffee and caffeine. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12619674/
[4] Cornelis M. C. The impact of caffeine and coffee on human health. Nutrients, 2019. https://www.mdpi.com/2072-6643/11/2/416
[5] Lipton R. B. et al. Caffeine in the management of patients with headache. Headache, 2017. https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.13061
[6] Sawynok J. Caffeine and pain. Pharmacological Reviews, 2011. https://pharmrev.aspetjournals.org/content/63/3/623
[7] American Migraine Foundation. Caffeine and Migraine. https://americanmigrainefoundation.org/resource-library/caffeine-and-migraine/